Quote | IceCure Medical Ltd. (NASDAQ:ICCM)
Last: | $0.73 |
---|---|
Change Percent: | 2.48% |
Open: | $0.721 |
Close: | $0.73 |
High: | $0.767 |
Low: | $0.721 |
Volume: | 61,473 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | IceCure Medical Ltd. (NASDAQ:ICCM)
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...
IceCure Medical to Provide Overview and Share Recent Progress at Northland Capital Markets Virtual Growth Conference on June 25, 2024 PR Newswire Recent insider open-market stock purchases demonstrate continued confidence in the Company CAESAREA, Israel , ...
Message Board Posts | IceCure Medical Ltd. (NASDAQ:ICCM)
Subject | By | Source | When |
---|---|---|---|
Cryoablation Takes Center Stage at American Society of | midastouch017 | investorshub | 05/01/2023 12:14:39 PM |
IceCure Medical to Provide Educational Support in a | midastouch017 | investorshub | 04/24/2023 12:07:54 PM |
IceCure's ProSense System Used in Endometriosis Cryoablation Study | midastouch017 | investorshub | 04/20/2023 12:15:14 PM |
I concur, this is a positive move. | midastouch017 | investorshub | 04/19/2023 3:00:58 PM |
that should save them some money, plus US | Paullee | investorshub | 04/19/2023 1:58:04 PM |
News, Short Squeeze, Breakout and More Instantly...
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...
IceCure Medical to Provide Overview and Share Recent Progress at Northland Capital Markets Virtual Growth Conference on June 25, 2024 PR Newswire Recent insider open-market stock purchases demonstrate continued confidence in the Company CAESAREA, Israel , ...
Positive Data from IceCure's Kidney Cancer Clinical Study Presented at Interventional Radiology Conference: Minimally Invasive Approach Results in Shorter Hospitalization and Minor Impact on Renal Function PR Newswire ICESECRET interim results, as previously announced, dem...